Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
| Molecular Weight | 1028.5 g/mol |
|---|---|
| Molecular Formula | C44H56F2N6O12S2Zn+2 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 20 |
| Rotatable Bond Count | 20 |
| Exact Mass | 1026.265712 g/mol |
| Monoisotopic Mass | 1026.265712 g/mol |
| Topological Polar Surface Area | 299 A^2 |
| Heavy Atom Count | 67 |
| Formal Charge | 2 |
| Complexity | 767 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
| 1 of 2 | |
|---|---|
| Drug Name | Rosuvastatin zinc |
| Active Ingredient | Rosuvastatin zinc |
| Dosage Form | Tablet |
| Route | oral |
| Strength | 5mg; 10mg; 40mg; 20mg |
| Market Status | Tentative Approval |
| Company | Watson Labs |
| 2 of 2 | |
|---|---|
| Drug Name | Rosuvastatin zinc |
| Active Ingredient | Rosuvastatin zinc |
| Dosage Form | Tablet |
| Route | oral |
| Strength | 5mg; 10mg; 40mg; 20mg |
| Market Status | Tentative Approval |
| Company | Watson Labs |
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Rosuvastatin Zinc manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rosuvastatin Zinc, including repackagers and relabelers. The FDA regulates Rosuvastatin Zinc manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rosuvastatin Zinc API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rosuvastatin Zinc manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rosuvastatin Zinc supplier is an individual or a company that provides Rosuvastatin Zinc active pharmaceutical ingredient (API) or Rosuvastatin Zinc finished formulations upon request. The Rosuvastatin Zinc suppliers may include Rosuvastatin Zinc API manufacturers, exporters, distributors and traders.
click here to find a list of Rosuvastatin Zinc suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Rosuvastatin Zinc Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rosuvastatin Zinc GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rosuvastatin Zinc GMP manufacturer or Rosuvastatin Zinc GMP API supplier for your needs.
A Rosuvastatin Zinc CoA (Certificate of Analysis) is a formal document that attests to Rosuvastatin Zinc's compliance with Rosuvastatin Zinc specifications and serves as a tool for batch-level quality control.
Rosuvastatin Zinc CoA mostly includes findings from lab analyses of a specific batch. For each Rosuvastatin Zinc CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rosuvastatin Zinc may be tested according to a variety of international standards, such as European Pharmacopoeia (Rosuvastatin Zinc EP), Rosuvastatin Zinc JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rosuvastatin Zinc USP).
LOOKING FOR A SUPPLIER?
